The call will be open to all interested parties and may be accessed by using the following information:
CONFERENCE CALL ACCESS
Domestic Dial In: (800) 374-0147
International Dial In: (706) 634-5431
Conference Call ID: 6301034
Investors can access the call in a "listen only" mode via the Internet at http://www.streetevents.com.
In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, May 1, 2007 at 12:00 PM Eastern Daylight Time until Tuesday, May 15, 2007 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:
REBROADCAST ACCESS
Domestic Dial In: (800) 642-1687
International Dial In: (706) 645-9291
Participant Code: 6301034
Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Contact:
Kathleen Makrakis - VP, Investor Relations
kathleen.makrakis@alpharma.com
908-566-3826
